{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T18:28:37Z","timestamp":1772476117051,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1136\/ijgc-2021-002511","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T14:43:46Z","timestamp":1618497826000},"page":"883-887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer during COVID-19 pandemic"],"prefix":"10.1016","volume":"31","author":[{"given":"Ali","family":"Ayhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5874-7324","authenticated-orcid":false,"given":"Safak","family":"Yilmaz Baran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-7070","authenticated-orcid":false,"given":"Dogan","family":"Vatansever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsen","family":"Dogan Durdag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin","family":"Akilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husnu","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-552X","authenticated-orcid":false,"given":"Cagatay","family":"Taskiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2021-002511_bb0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO Consensus Conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2021-002511_bb0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4251\/wjgo.v2.i2.68","article-title":"Hyperthermic intraperitoneal chemotherapy: rationale and technique","volume":"2","author":"Gonz\u00e1lez-Moreno","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"10.1136\/ijgc-2021-002511_bb0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2021-002511_bb0025","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study","volume":"22","author":"Spiliotis","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1136\/ijgc-2021-002511_bb0030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/ijgc-2020-001419","article-title":"COVID-19 global pandemic: options for management of gynecologic cancers","volume":"30","author":"Ramirez","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002511_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000827","article-title":"ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies","volume":"5","author":"Colombo","year":"2020","journal-title":"ESMO Open"},{"key":"10.1136\/ijgc-2021-002511_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101729","article-title":"Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF","volume":"49","author":"Akladios","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1136\/ijgc-2021-002511_bb0045","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ygyno.2020.11.014","article-title":"Perioperative SARS-CoV-2 infection among women undergoing major gynecologic cancer surgery in the COVID-19 era: a nationwide, cohort study from Turkey","volume":"160","author":"Ayhan","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002511_bb0050","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jviscsurg.2020.04.013","article-title":"Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic: proposals for prioritization from the RENAPE and BIG-RENAPE groups","volume":"157","author":"Glehen","year":"2020","journal-title":"J Visc Surg"},{"key":"10.1136\/ijgc-2021-002511_bb0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3906\/sag-2004-187","article-title":"COVID-19 outbreak control, example of Ministry of health of turkey","volume":"50","author":"Demirbilek","year":"2020","journal-title":"Turk J Med Sci"},{"key":"10.1136\/ijgc-2021-002511_bb0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1136\/ijgc-2021-002511_bb0065","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/ijgc-2020-001975","article-title":"Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective","volume":"30","author":"Tsibulak","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002511_bb0070","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1038\/bjc.2015.48","article-title":"Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? systematic review","volume":"112(Suppl 1)","author":"Neal","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2021-002511_bb0075","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jamaoncol.2020.0980","article-title":"SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China","volume":"6","author":"Yu","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1136\/ijgc-2021-002511_bb0080","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","article-title":"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China","volume":"31","author":"Zhang","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2021-002511_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(20)31182-X","article-title":"Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study","volume":"396","author":"COVIDSurg Collaborative","year":"2020","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2021-002511_bb0090","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ygyno.2020.12.013","article-title":"Maintaining surgical care delivery during the COVID-19 pandemic: a comparative cohort study at a tertiary gynecological cancer centre","volume":"160","author":"Leung","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002511_bb0095","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/ijgc-2020-001489","article-title":"COVID-19 global pandemic: options for management of gynecologic cancers. The experience in surgical management of ovarian cancer in the second highest affected Italian region","volume":"30","author":"Perrone","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002511_bb0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ygyno.2020.09.030","article-title":"COVID-19 free oncologic surgical hub: the experience of reallocation of a gynecologic oncology unit during pandemic outbreak","volume":"161","author":"Perrone","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002511_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejogrb.2014.05.018","article-title":"Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC\u2013IV ovarian cancer. critical analysis in elderly patients","volume":"179","author":"Cascales-Campos","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1136\/ijgc-2021-002511_bb0110","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ejso.2013.06.022","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial ovarian carcinoma: upfront therapy, at first recurrence, or later?","volume":"39","author":"Gonzalez Bayon","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1136\/ijgc-2021-002511_bb0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/ijgc-2018-000099","article-title":"Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis","volume":"29","author":"Angeles","year":"2019","journal-title":"Int J Gynecol Cancer"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24004171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24004171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2021-002511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:39:06Z","timestamp":1753101546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24004171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1048891X24004171"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2021-002511","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer during COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2021-002511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright This article is made freely available for use in accordance with BMJ\u2019s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.","name":"copyright","label":"Copyright"}]}}